ArticleThe Journal of clinical investigation2023

RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition.

Amy C Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.